325 related articles for article (PubMed ID: 21906355)
1. The ADAMs family of proteases: new biomarkers and therapeutic targets for cancer?
Duffy MJ; Mullooly M; O'Donovan N; Sukor S; Crown J; Pierce A; McGowan PM
Clin Proteomics; 2011 Jun; 8(1):9. PubMed ID: 21906355
[TBL] [Abstract][Full Text] [Related]
2. The ADAMs family of proteases as targets for the treatment of cancer.
Mullooly M; McGowan PM; Crown J; Duffy MJ
Cancer Biol Ther; 2016 Aug; 17(8):870-80. PubMed ID: 27115328
[TBL] [Abstract][Full Text] [Related]
3. Functions of 'A disintegrin and metalloproteases (ADAMs)' in the mammalian nervous system.
Hsia HE; Tüshaus J; Brummer T; Zheng Y; Scilabra SD; Lichtenthaler SF
Cell Mol Life Sci; 2019 Aug; 76(16):3055-3081. PubMed ID: 31236626
[TBL] [Abstract][Full Text] [Related]
4. ADAMs in cancer cell proliferation and progression.
Mochizuki S; Okada Y
Cancer Sci; 2007 May; 98(5):621-8. PubMed ID: 17355265
[TBL] [Abstract][Full Text] [Related]
5. Role of ADAMs in cancer formation and progression.
Duffy MJ; McKiernan E; O'Donovan N; McGowan PM
Clin Cancer Res; 2009 Feb; 15(4):1140-4. PubMed ID: 19228719
[TBL] [Abstract][Full Text] [Related]
6. ADAM-family metalloproteinases in lung inflammation: potential therapeutic targets.
Dreymueller D; Uhlig S; Ludwig A
Am J Physiol Lung Cell Mol Physiol; 2015 Feb; 308(4):L325-43. PubMed ID: 25480335
[TBL] [Abstract][Full Text] [Related]
7. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands.
Sahin U; Weskamp G; Kelly K; Zhou HM; Higashiyama S; Peschon J; Hartmann D; Saftig P; Blobel CP
J Cell Biol; 2004 Mar; 164(5):769-79. PubMed ID: 14993236
[TBL] [Abstract][Full Text] [Related]
8. Differential surface expression of ADAM10 and ADAM17 on human T lymphocytes and tumor cells.
Ebsen H; Schröder A; Kabelitz D; Janssen O
PLoS One; 2013; 8(10):e76853. PubMed ID: 24130797
[TBL] [Abstract][Full Text] [Related]
9. Regulation of A disintegrin and metalloproteinase (ADAM) family sheddases ADAM10 and ADAM17: The emerging role of tetraspanins and rhomboids.
Matthews AL; Noy PJ; Reyat JS; Tomlinson MG
Platelets; 2017 Jun; 28(4):333-341. PubMed ID: 27256961
[TBL] [Abstract][Full Text] [Related]
10. ADAM Proteases and Gastrointestinal Function.
Jones JC; Rustagi S; Dempsey PJ
Annu Rev Physiol; 2016; 78():243-76. PubMed ID: 26667078
[TBL] [Abstract][Full Text] [Related]
11. Expression and cellular localization of metalloproteases ADAMs in high graded carotid artery lesions.
Pelisek J; Pongratz J; Deutsch L; Reeps C; Stadlbauer T; Eckstein HH
Scand J Clin Lab Invest; 2012 Dec; 72(8):648-56. PubMed ID: 23101757
[TBL] [Abstract][Full Text] [Related]
12. The role of ADAMs in disease pathophysiology.
Duffy MJ; McKiernan E; O'Donovan N; McGowan PM
Clin Chim Acta; 2009 May; 403(1-2):31-6. PubMed ID: 19408347
[TBL] [Abstract][Full Text] [Related]
13. Subcellular localization and activation of ADAM proteases in the context of FasL shedding in T lymphocytes.
Ebsen H; Lettau M; Kabelitz D; Janssen O
Mol Immunol; 2015 Jun; 65(2):416-28. PubMed ID: 25745808
[TBL] [Abstract][Full Text] [Related]
14. The ADAM metalloproteinases.
Edwards DR; Handsley MM; Pennington CJ
Mol Aspects Med; 2008 Oct; 29(5):258-89. PubMed ID: 18762209
[TBL] [Abstract][Full Text] [Related]
15. Proteolytic processing of delta-like 1 by ADAM proteases.
Dyczynska E; Sun D; Yi H; Sehara-Fujisawa A; Blobel CP; Zolkiewska A
J Biol Chem; 2007 Jan; 282(1):436-44. PubMed ID: 17107962
[TBL] [Abstract][Full Text] [Related]
16. The disintegrin-metalloproteinases ADAM9, ADAM12, and ADAM15 are upregulated in gastric cancer.
Carl-McGrath S; Lendeckel U; Ebert M; Roessner A; Röcken C
Int J Oncol; 2005 Jan; 26(1):17-24. PubMed ID: 15586220
[TBL] [Abstract][Full Text] [Related]
17. (Make) stick and cut loose--disintegrin metalloproteases in development and disease.
Tousseyn T; Jorissen E; Reiss K; Hartmann D
Birth Defects Res C Embryo Today; 2006 Mar; 78(1):24-46. PubMed ID: 16622847
[TBL] [Abstract][Full Text] [Related]
18. ADAM9 silencing inhibits breast tumor cells transmigration through blood and lymphatic endothelial cells.
Micocci KC; Moritz MN; Lino RL; Fernandes LR; Lima AG; Figueiredo CC; Morandi V; Selistre-de-Araujo HS
Biochimie; 2016; 128-129():174-82. PubMed ID: 27554339
[TBL] [Abstract][Full Text] [Related]
19. Renal ADAM10 and 17: Their Physiological and Medical Meanings.
Kato T; Hagiyama M; Ito A
Front Cell Dev Biol; 2018; 6():153. PubMed ID: 30460232
[TBL] [Abstract][Full Text] [Related]
20. Synthesis and in vitro Evaluation of ADAM10 and ADAM17 Highly Selective Bioimaging Probes.
Camodeca C; Nuti E; Tosetti F; Poggi A; D'Arrigo C; Zocchi MR; Rossello A
ChemMedChem; 2018 Oct; 13(19):2119-2131. PubMed ID: 30102846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
